US 2018/0008567 A1 · COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF USING THE SAME

Abstract

The present disclosure relates to the compositions, formulations and methods of treating or preventing diseases mediated by peroxisome proliferator-activated receptors (PPARs) by administration of 15-HEPE.

Claims11

Dependent claims

A method for treating or preventing a disease mediated by peroxisome proliferator-activated receptors (PPARs) in a subject comprising, administering to the subject pharmaceutical composition comprising 15-HEPE to treat or prevent the disease in the subject.

Dependencies are inferred from the claim text.

Facts

Application

15/542,668Filed 15 Jan 2016

Priority

16 Jan 2015

Published

11 Jan 2018

Term ends

Not estimatedThe source records don’t support an estimate.

Classification22 codes

A61K 31/202
Having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids: having three or more double…
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 9/48
Medicinal preparations characterised by special physical form: preparations in capsules, e.g. of gelatin, of chocolate
A61P 1/00
Drugs for disorders of the alimentary tract or the digestive system

Abstract

Claims11

Dependent claims

Dependencies are inferred from the claim text.

Compositions comprising 15-hepe and methods of using the same

Life of this patent

Abstract

Claims11

Compositions comprising 15-hepe and methods of using the same

Life of this patent

Abstract

Claims11